These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 3097031

  • 1. Structure and function of human tissue-type plasminogen activator (t-PA).
    van Zonneveld AJ, Veerman H, MacDonald ME, van Mourik JA, Pannekoek H.
    J Cell Biochem; 1986; 32(3):169-78. PubMed ID: 3097031
    [Abstract] [Full Text] [Related]

  • 2. Autonomous functions of structural domains on human tissue-type plasminogen activator.
    van Zonneveld AJ, Veerman H, Pannekoek H.
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4670-4. PubMed ID: 3088564
    [Abstract] [Full Text] [Related]

  • 3. Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.
    de Vries C, Veerman H, Nesheim ME, Pannekoek H.
    Thromb Haemost; 1991 Mar 04; 65(3):280-5. PubMed ID: 1904654
    [Abstract] [Full Text] [Related]

  • 4. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L, Lijnen HR, Van Nuffelen A, Demarsin E, Collen D.
    Thromb Haemost; 1990 Aug 13; 64(1):53-60. PubMed ID: 2148847
    [Abstract] [Full Text] [Related]

  • 5. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 13; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 6. [Expression and activity of tissue-type plasminogen activator mutant reteplase with deletion of PAI-1 binding sites].
    Zhu MC, Zhan Z, Wang YJ, Liu CG, Shi Y, Cai Q.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep 13; 21(5):565-9. PubMed ID: 16143058
    [Abstract] [Full Text] [Related]

  • 7. Fibrin affinity and clearance of t-PA deletion and substitution analogues.
    Johannessen M, Diness V, Pingel K, Petersen LC, Rao D, Lioubin P, O'Hara P, Mulvihill E.
    Thromb Haemost; 1990 Feb 19; 63(1):54-9. PubMed ID: 2111048
    [Abstract] [Full Text] [Related]

  • 8. Mapping of epitopes on human tissue-type plasminogen activator with recombinant deletion mutant proteins.
    van Zonneveld AJ, Veerman H, Brakenhoff JP, Aarden LA, Cajot JF, Pannekoek H.
    Thromb Haemost; 1987 Feb 03; 57(1):82-6. PubMed ID: 2438798
    [Abstract] [Full Text] [Related]

  • 9. Serpin-resistant mutants of human tissue-type plasminogen activator.
    Madison EL, Goldsmith EJ, Gerard RD, Gething MJ, Sambrook JF.
    Nature; 1989 Jun 29; 339(6227):721-4. PubMed ID: 2500599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.
    Fujii S, Sobel BE.
    Thromb Haemost; 1992 Feb 03; 67(2):233-8. PubMed ID: 1621243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M, Philips M, Thorsen S, Selmer J, Zeuthen J.
    Thromb Haemost; 1987 Oct 28; 58(3):872-8. PubMed ID: 3124286
    [Abstract] [Full Text] [Related]

  • 17. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
    Ikenaka Y, Yajima K, Yahara H, Maruyama H, Matsumoto K, Okada K, Ueshima S, Matsuo O.
    Blood Coagul Fibrinolysis; 1992 Aug 28; 3(4):381-7. PubMed ID: 1330023
    [Abstract] [Full Text] [Related]

  • 18. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.
    Yahara H, Matsumoto K, Maruyama H, Nagaoka T, Ikenaka Y, Yajima K, Fukao H, Ueshima S, Matsuo O.
    Thromb Haemost; 1994 Dec 28; 72(6):893-9. PubMed ID: 7740460
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domains.
    Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D.
    J Biol Chem; 1990 Apr 05; 265(10):5677-83. PubMed ID: 2156824
    [Abstract] [Full Text] [Related]

  • 20. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 05; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.